You have 9 free searches left this month | for more free features.

lanadelumab

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hereditary Angioedema (HAE) Trial in China (Lanadelumab)

Recruiting
  • Hereditary Angioedema (HAE)
  • Lanadelumab
  • Guangzhou, Guangdong, China
  • +3 more
Jul 13, 2022

Lanadelumab in Participants With Hereditary Angioedema

Recruiting
  • Hereditary Angioedema (HAE)
  • Lanadelumab
  • Tokyo, T, Japan
    Takeda selected site
Jun 22, 2022

Healthy Volunteers Trial in Lincoln (Lanadelumab, Placebo)

Completed
  • Healthy Volunteers
  • Lanadelumab
  • Placebo
  • Lincoln, Nebraska
    Celerion
Dec 14, 2021

Angioedema Trial in United States (Lanadelumab)

Recruiting
  • Angioedema
  • Lanadelumab
  • Birmingham, Alabama
  • +7 more
Mar 30, 2022

Lung Injury Trial in Melbourne (Lanadelumab, Saline control)

Recruiting
  • Lung Injury
  • Lanadelumab
  • Saline control
  • Melbourne, Victoria, Australia
    St Vincent's Hospital Melbourne
May 4, 2022

Healthy Volunteers Trial in Cypress (Lanadelumab)

Completed
  • Healthy Volunteers
  • Lanadelumab
  • Cypress, California
    WCCT Global, Inc.
May 13, 2021

Hereditary Angioedema (HAE) Trial in Japan (Lanadelumab)

Completed
  • Hereditary Angioedema (HAE)
  • Lanadelumab
  • Toyohashi-shi, Aichi-Ken, Japan
  • +11 more
Sep 23, 2021

Angioedema Trial in Worldwide (Lanadelumab, Placebo)

Completed
  • Angioedema
  • Lanadelumab
  • Placebo
  • Birmingham, Alabama
  • +44 more
Oct 24, 2022

COVID-19 Pneumonia Trial (Lanadelumab, Placebo)

Withdrawn
  • COVID-19 Pneumonia
  • Lanadelumab
  • Placebo
  • (no location specified)
Oct 9, 2020

COVID-19 Trial in Worldwide (Standard of care, Apremilast, Apremilast )

Completed
  • COVID-19
  • Standard of care
  • +6 more
  • Anniston, Alabama
  • +58 more
Jun 23, 2022